Literature DB >> 11036658

Methods for generating multivalent and bispecific antibody fragments.

I Tomlinson1, P Holliger.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11036658     DOI： 10.1016/s0076-6879(00)26070-9

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  6 in total

1.  Isolation of receptor-ligand pairs by capture of long-lived multivalent interaction complexes.

Authors:  Ruud M T de Wildt; Ian M Tomlinson; Jennifer L Ong; Philipp Holliger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

2.  Modeling the three-dimensional structures of an unbound single-chain variable fragment (scFv) and its hypothetical complex with a Corynespora cassiicola toxin, cassiicolin.

Authors:  Adeel Malik; Ahmad Firoz; Vivekanand Jha; Elumalai Sunderasan; Shandar Ahmad
Journal:  J Mol Model       Date:  2010-03-16       Impact factor: 1.810

Review 3.  Ligand-targeted delivery of therapeutic siRNA.

Authors:  Yutaka Ikeda; Kazunari Taira
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

4.  Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity.

Authors:  Sharareh Emadi; Hedieh Barkhordarian; Min S Wang; Philip Schulz; Michael R Sierks
Journal:  J Mol Biol       Date:  2007-03-07       Impact factor: 5.469

5.  Bifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragments.

Authors:  David C Butler; Anne Messer
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

6.  Isolation, identification and expression of specific human CD133 antibodies.

Authors:  Jing Xia; Ying Zhang; Jun Qian; Xiaojun Zhu; Yafen Zhang; Jianqiong Zhang; Gang Zhao
Journal:  Sci Rep       Date:  2013-11-25       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.